Bracco Diagnostics Inc

Bracco, the parent company of Bracco Diagnostics, was founded in 1927. It has been owned and operated for three generations by the Bracco family. The company is an integrated health care group and a world leader in global solutions for the diagnostic imaging field. Born as a pharmaceuticals trading concern, the company has developed an independent industrial production and research activity, specializing its research and development capacities in a specific field - diagnostic imaging. Bracco's laboratories discovered and developed the iopamidol molecule, the first ready-to-use non-ionic contrast medium. In 1994, the company expanded into the United States. It founded Bracco Diagnostics and Bracco Research USA in Princeton, N.J. The United States represents the group's largest market in the sector of contrast agents for medical diagnostics.

Bracco Diagnostics Inc is a pharmaceutical company based in Plainsboro, NJ, specializing in the development and distribution of diagnostic imaging products for healthcare professionals. With a focus on innovation and quality, Bracco Diagnostics Inc aims to provide cutting-edge solutions to support accurate diagnoses and improve patient care in medical settings. Generated from their business information